Your browser doesn't support javascript.
loading
Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells.
Schurman, L; McCarthy, A D; Sedlinsky, C; Gangoiti, M V; Arnol, V; Bruzzone, L; Cortizo, A M.
Affiliation
  • Schurman L; Centro de Endocrinología y Metabolismo, Hospital Francés, Buenos Aires.
Exp Clin Endocrinol Diabetes ; 116(6): 333-40, 2008 Jun.
Article in En | MEDLINE | ID: mdl-18273753
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoblasts / Glycation End Products, Advanced / Metformin Limits: Animals Language: En Journal: Exp Clin Endocrinol Diabetes Journal subject: ENDOCRINOLOGIA Year: 2008 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoblasts / Glycation End Products, Advanced / Metformin Limits: Animals Language: En Journal: Exp Clin Endocrinol Diabetes Journal subject: ENDOCRINOLOGIA Year: 2008 Document type: Article